Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2010-03-09
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the efficacy, safety and tolerability of SB-742457
versus placebo in subjects with mild-to-moderate Alzheimer's disease. SB-742457 is an
experimental treatment which increases the levels of certain chemicals in the brain that are
often decreased in patients with Alzheimer's disease.